Journal of International Oncology››2012,Vol. 39››Issue (7): 538-540.

Previous ArticlesNext Articles

Small interfering RNA in gastrointestinal cancer

JU Feng, ZUO Jun-Bo, XIA Jia-Zeng

  1. Department of General Surgery, Wuxi Second Hospital, Nanjing Medical University, Wuxi 214002, China
  • Online:2012-08-06Published:2012-08-06
  • Contact:XIA jia-zeng, E-mail: jzxia_99@yahoo.com E-mail:jzxia_99@yahoo.com

Abstract:SiRNA comes from doublestranded RNA, which is processed into a small molecular fragment by Dicer. 2125nt siRNA, as the key effector molecules to the RNAi process, can inhibit gene expression with high specificity and high efficiency in mammalian cells. Currently, RNAi has been widely applied in a variety of cancer. RNAi has many active research explorations of the tumor development, metastasis and treatment in gastrointestinal cancer.

Key words:RNA, small interfering,RNA interference,Gastrointestinal neoplasms